|
Dear Friends of Verseon,
Happy 2025!
As the new year begins, we've taken some time to reflect on 2024 and our
vision for the year ahead.
|
|
VersAI trains models 3,000
times faster than current
state-of-the-art Google
AutoML
|
|
|
|
|
Verseon has built a seamless
platform... to design
never-before-made novel drug
molecules on the computer
|
|
|
|
New tech unlocks seemingly
infinite chemical space that
could generate trillions of
dollars per year
|
|
|
|
NeuTherX and Verseon partner
to turbocharge preclinical
drug development using
scalable organoid testing
|
|
|
|
Verseon's newly patented
PROACs prevent heart attacks
and strokes without the
bleeding risks posed by
other drugs
|
|
|
As Verseon continues to develop therapeutics no one else in the industry
can, we hope to see significant ramp-up of the company's growth in 2025.
Wishing you a happy and prosperous New Year,
Adityo
|